Voya Investment Management LLC Athira Pharma, Inc. Transaction History

Voya Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Feb 07, 2025	BUY	$2.26 - $4.22 $28,385 - $53,003	12,560 New	12,560 $31,000
Q3 2022 Feb 07, 2025	BUY	$2.93 - $3.96 $36,800 - $49,737	12,560 New	12,560 $37,000
Q4 2021 Feb 14, 2022	BUY	$9.17 - $16.39 $1,723 - $3,081	188 Added 1.52%	12,560 $164,000
Q2 2021 Aug 16, 2021	BUY	$10.24 - $20.87 $126,689 - $258,203	12,372 New	12,372 $127,000

19M

23.6K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $17.8M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.